首页
登录
职称英语
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
A personalized blood test that can identify tumor(肿瘤)DNA could be the first
游客
2023-08-27
23
管理
问题
A personalized blood test that can identify tumor(肿瘤)DNA could be the first step towards a long-promised revolution in the way cancer is treated.
In the short term, the test—reported by Victor Velculescu of Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and his colleagues in Science Translational Medicine—could be used to spot cancer recurrence before tumor growth shows up on scans, meaning that treatment could be started earlier.
The test detects genetic rearrangements that distinguish cancer cells from normal cells. Eventually it might also pave the way for more personalized cancer treatments tailored to the genetic signature of individuals’ tumors.
Doctors already classify cancers by some of the genes that get switched on by the disease, and use this to guide treatment in some cases. For example, breast cancers are often divided into those that express oestrogen(雌激素)receptors on their surface and are therefore likely to respond to the drug tamoxifen(三苯氧胺), and those that don’t.
Genes have also been identified that predict whether a variety of cancers are resistant to radiotherapy and certain drugs, and might therefore need a different sort of treatment. It is also possible to stratify(使分层)cancers into aggressive and non-aggressive subtypes(类型)according to their genetic make-up.
But that’s just the beginning. In the future, pretty much all cancers are likely to be defined by the genetic pathways that drive their growth, rather than where in the body they manifest themselves. And because cancers mutate as they grow, it should be possible to track these changes and tailor patients’ therapies accordingly.
Velculescu’s test is a step towards this. The real breakthrough will come when such blood tests become sophisticated enough to reveal how tumors are changing over time, rather than simply spotting that they have come back. That should truly revolutionize cancer treatment, enabling the most effective combinations of drugs to be tailored to individual patients—and without the need for painful tissue biopsies(生检采样). [br] If the blood test technique gets matured, we can see how______.
选项
答案
tumors are changing over time
解析
本题考查该血液检测技术成熟后的结果。根据定位句可知,这项血液检测技术成熟后,可揭示肿瘤变化的过程,而这将是真正的突破。题干中的gets matured是原文中的become sophisticated的同义转述,题干要求将主句补允完整,而原句中when such blood tests become sophisticated enough对应的结果是动词不定式短语to reveal how turnouts are changing over time,因此根据题干语法要求,可知该短语中how所引导的宾语从句的内容tumors are changing over time是本题答案。
转载请注明原文地址:https://tihaiku.com/zcyy/2961546.html
相关试题推荐
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
Apersonalizedbloodtestthatcanidentifytumor(肿瘤)DNAcouldbethefirst
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
[originaltext]M:SoJanice,youwerelookingatidentifyingdifferenttalentsi
随机试题
Executivecoachingisprimarilyconcernedwithconfidentialone-to-onediscu
GaspricewarningascoldMarchleadstoshortsuppliesA)Thecolds
Haiti’sTourismA)LikemanyofitsCaribbeanneighb
Canyouimaginehowyouwouldfeelifyoufelldangerouslyillandcouldnot
[originaltext]M:Janetisquiteinterestedincamping,isn’tshe?W:Yes,sheo
定期进行护理安全隐患报告,属于风险管理的A.风险鉴别 B.风险评估 C.风险
在绝大多数人中A、胆囊管汇合于右肝管 B、胆囊管汇合于肝总管 C、胆囊管汇合
男性,57岁,进食后梗噎感半年,近一个月只能吃软食,伴胸骨后疼痛,饮酒近40年,
心导管检查右心室血氧含量高于右心房的先心病是( )。A.房间隔缺损 B.室间
关于施工总承包管理方主要特征的说法,正确的是()。A.在平等条件下可通过竞标获
最新回复
(
0
)